Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line

Pigment Cell and Melanoma Research

Volumn 28, Issue 3, 2015, Pages 357-359

  Yu, Xiaoxing ^a   Ambrosini, Grazia ^b,c   Roszik, Jason ^a   Eterovic, Agda Karina ^a   Stempke Hale, Katherine ^a   Seftor, Elisabeth A ^d   Chattopadhyay, Chandrani ^a   Grimm, Elizabeth ^a   Carvajal, Richard D ^b,c   Hendrix, Mary J C ^d   Hodi, F Stephen ^e   Schwartz, Gary K ^b,c   Woodman, Scott E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Department of Medicine   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; G ALPHA PROTEIN SUBUNIT GNA11; G ALPHA PROTEIN SUBUNIT GNAQ; K RAS PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MICROSATELLITE DNA; ONCOPROTEIN; PROTEIN P21; RAS PROTEIN;

ARTICLE; CELL MUTANT; CUTANEOUS MELANOMA; GENE MUTATION; GENETIC ANALYSIS; IN VITRO STUDY; MASS SPECTROMETRY; MELANOMA CELL LINE; MISSENSE MUTATION; PRIMARY TUMOR; PSEUDOGENE; SHORT TANDEM REPEAT; TANDEM REPEAT; UVEA MELANOMA; GENETICS; HUMAN; MELANOMA; MUTATION; NUCLEOTIDE REPEAT; TUMOR CELL LINE; UVEA TUMOR;

CELL LINE, TUMOR; HUMANS; MELANOMA; MICROSATELLITE REPEATS; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; UVEAL NEOPLASMS;

EID: 84926681610     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12345     Document Type: Article

References (12)

1. Carvajal, R.D., Sosman, J.A., Quevedo, J.F. et al. (2014). Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. J. Am. Med. Assoc. 311, 23.
2. Cruz, F., Rubin, B.P., Wilson, D., Town, A., Schroeder, A., Haley, A., Bainbridge, T., Heinrich, M.C., and Corless, C.L. (2003). Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res. 63, 5761-5766.
3. Daniels, A.B., Lee, J.E., Macconaill, L.E. et al. (2012). High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest. Ophthalmol. Vis. Sci. 53, 6991-6996.
4. Davies, M.A., Stemke-Hale, K., Lin, E. et al. (2009). Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin. Cancer Res. 15, 7538-7546.
5. Folberg, R., Kadkol, S.S., Frenkel, S., Valyi-Nagy, K., Jager, M.J., Pe'er, J., and Maniotis, A.J. (2008). Authenticating cell lines in ophthalmic research laboratories. Invest. Ophthalmol. Vis. Sci. 49, 4697-4701.
6. Griewank, K.G., Yu, X., Khalili, J., Sozen, M.M., Stempke-Hale, K., Bernatchez, C., Wardell, S., Bastian, B.C., and Woodman, S.E. (2012). Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 25, 182-187.
7. Janssen, C.S., Sibbett, R., Henriquez, F.L., McKay, I.C., Kemp, E.G., and Roberts, F. (2008). The T1799A point mutation is present in posterior uveal melanoma. Br. J. Cancer 99, 1673-1677.
8. Maat, W., Kilic, E., Luyten, G.P.M., De Klein, A., Jager, M.J., Gruis, N.A., and Van Der Velden, P.A. (2008). Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest. Ophthalmol. Vis. Sci. 49, 23-27.
9. Sithanandam, G., Druck, T., Cannizzaro, L.A., Leuzzi, G., Huebner, K., and Rapp, U.R. (1992). B-raf and a B-raf pseudogene are located on 7q in man. Oncogene 7, 795-799.
10. Van Raamsdonk, C.D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O'Brien, J.M., Simpson, E.M., Barsh, G.S., and Bastian, B.C. (2009). Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602.
11. Van Raamsdonk, C.D., Griewank, K.G., Crosby, M.B. et al. (2010). Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191-2199.
12. Welch, D., Bisi, J., Miller, B., Gilmore, L., Conaway, D., Yohem, K., Seftor, E., Nakajima, M., and Hendrix, M. (1990). Characterization of C8161, a highly invasive and spontaneously metastatic human malignant melanoma cell line. Clin. Exp. Metastasis 8, 81.